DrugDashboards

Market view

melaleuca, melaleuca quinquenervia · Injection, Solution

1 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

Same drug class

Other molecules FDA puts in Non-Standardized Pollen Allergenic Extract, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Melaleuca, melaleuca quinquenervia in shortage right now?
No. FDA does not currently list Melaleuca, melaleuca quinquenervia in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Melaleuca, melaleuca quinquenervia?
1 company has marketed Melaleuca, melaleuca quinquenervia in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.